☆ 4.6 Article

Stem cell therapy for Alport syndrome: the hope beyond the hype

NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)

Get Full Text
Add to Collection

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 24, Issue 3, Pages 731-734

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfn722

Keywords

alport syndrome; bone marrow transplantation; renal fibrosis; stem cell therapy

Categories

Transplantation Urology & Nephrology

Funding

  1. Association pour l'Information et la Recherche sur les maladies renale Genetiques France
  2. KfH-Foundation Preventive Medicine

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Transplantation

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association

Alberto Ortiz, Christoph Wanner, Ron Gansevoort

Summary: The European Society of Cardiology 2021 guideline on cardiovascular disease prevention has significant implications for CV risk screening and kidney health. The guideline proposes specific strategies for individuals with established CVD, diabetes, hypercholesterolemia, or CKD. This includes the assessment of albuminuria as an entry-level step in CVD risk assessment, which could change current clinical practice. Further research is needed to determine the optimal method for CV risk assessment, including CKD assessment in the general population.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Add to Collection
Editorial Material Urology & Nephrology

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association

Alberto Ortiz, Christoph Wanner, Ron Gansevoort, Era Council

Summary: The European Society of Cardiology's 2021 guideline on cardiovascular disease prevention has important implications for CV risk screening and kidney health. It emphasizes the need for categorizing individuals based on established conditions such as atherosclerotic CVD, diabetes, hypercholesterolemia, or chronic kidney disease. The inclusion of albuminuria as a step in CVD risk assessment should change clinical practice. Further research is needed to determine the optimal method for assessing CV risk in the general population, including the role of systematic screening for CKD.

CLINICAL KIDNEY JOURNAL (2023)

Add to Collection
Correction Biochemistry & Molecular Biology

Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria (vol 29, pg 1186, 2021)

Judy Savige, Helen Storey, Elizabeth Watson, Jens Michael Hertz, Constantinos Deltas, Alessandra Renieri, Francesca Mari, Pascale Hilbert, Pavlina Plevova, Peter Byers, Agne Cerkauskaite, Martin Gregory, Rimante Cerkauskiene, Danica Galesic Ljubanovic, Francesca Becherucci, Carmela Errichiello, Laura Massella, Valeria Aiello, Rachel Lennon, Louise Hopkinson, Ania Koziell, Adrian Lungu, Hansjorg Martin Rothe, Julia Hoefele, Miriam Zacchia, Tamara Nikuseva Martic, Asheeta Gupta, Albertien van Eerde, Susie Gear, Samuela Landini, Viviana Palazzo, Laith al-Rabadi, Kathleen Claes, Anniek Corveleyn, Evelien Van Hoof, Micheel van Geel, Maggie Williams, Emma Ashton, Hendica Belge, Elisabeth Ars, Agnieszka Bierzynska, Concetta Gangemi, Beata S. Lipska-Zietkiewicz

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Add to Collection
Article Genetics & Heredity

Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes

Derralynn A. Hughes, Daniel G. Bichet, Roberto Giugliani, Robert J. Hopkin, Eva Krusinska, Kathleen Nicholls, Iacopo Olivotto, Ulla Feldt-Rasmussen, Norio Sakai, Nina Skuban, Gere Sunder-Plassmann, Roser Torra, William R. Wilcox

Summary: Fabry disease is a rare disorder caused by gene variants that results in enzyme deficiency and accumulation of lipids. This study evaluated the incidence of clinical events in Fabry patients treated with migalastat. The results showed that 17.5% of patients experienced 22 clinical events during long-term treatment, with a rate of 48.3 events per 1000 patient-years. Baseline characteristics such as gender, age, prior treatment, and kidney function were associated with the incidence of clinical events.

JOURNAL OF MEDICAL GENETICS (2023)

Add to Collection
Article Biochemistry & Molecular Biology

Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence

Andrea Ribeiro, Feiyue Liu, Matthias Srebrzynski, Simone Rother, Karina Adamowicz, Marta Wadowska, Stefanie Steiger, Hans-Joachim Anders, Christoph Schmaderer, Joanna Koziel, Maciej Lech

Summary: In this study, the impact of uremic toxin indoxyl sulfate on macrophages and tubular epithelial cells and its role in modulating the response to lipopolysaccharide (LPS) were investigated. Indoxyl sulfate, which accumulates in the blood of patients with chronic kidney disease (CKD), was found to induce low-grade inflammation and modulate macrophage function. Additionally, it was shown to enhance the inflammatory response associated with LPS and contribute to the senescence of tubular epithelial cells during injury.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection
Article Transplantation

The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC)

Paola Romagnani, A. Richard Kitching, Nelson Leung, Hans-Joachim Anders

Summary: Glomerulonephritis (GN) is a diverse group of immune-mediated disorders, which cannot be properly classified or treated based on histological patterns alone. To overcome this problem, a new classification system is proposed that considers disease category, immunological activity, and chronicity, which will guide the therapeutic approach.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Add to Collection
Article Transplantation

CKD therapy to improve outcomes of immune-mediated glomerular diseases

Hans-Joachim Anders, Gema M. Fernandez-Juarez, Augusto Vaglio, Paola Romagnani, Juergen Floege

Summary: The management of immune-mediated kidney diseases focuses on controlling the underlying immune disease process and the non-immune mechanisms of chronic kidney disease (CKD) progression. Non-pharmacological interventions, such as reducing salt intake and regular physical activity, along with approved drug interventions, can help attenuate CKD progression.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Add to Collection
Editorial Material Transplantation

Welcome editorial by the new NDT Editor-in-Chief

Hans-Joachim Anders

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Add to Collection
Article Ophthalmology

Drusen and Other Retinal Findings in People With IgA Glomerulonephritis

Ursula Greferath, Erica Fletcher, Judy Savige, Heather G. Mack

Summary: Retinal drusen are uncommon in IgA nephropathy, but they resemble drusen found in age-related macular degeneration. The IgA-staining deposits in the drusen are likely related to systemic deposition of IgA. The nature of cystic spaces in the drusen is still unknown. Further research on the retinas of people with glomerulonephritis is recommended.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Add to Collection
Review Biochemistry & Molecular Biology

Pathophysiology and targeted treatment of cholesterol crystal embolism and the related thrombotic angiopathy

Chongxu Shi, Elmina Mammadova-Bach, Cong Li, Dong Liu, Hans-Joachim Anders

Summary: Cholesterol crystal (CC) embolism is a complication of advanced atherosclerotic plaques primarily induced by interventional and surgical procedures. Prophylaxis through plaque stabilization and avoiding unnecessary catheter interventions is the main approach to CC embolism. Platelet inhibitors and anticoagulants may reduce the risk of vascular occlusions and tissue ischemia in case CC embolism occurs. Given the unmet medical need, effective treatment strategies for CC embolism are urgently needed.

FASEB JOURNAL (2023)

Add to Collection
Review Genetics & Heredity

A comparison of the ocular features in Pierson and Alport syndrome: a case report and literature review

Kieran Gooley, Peter Williams, Heather Mack, Victor Zhu, David Langsford, Tim Pianta, David Barit, Khalid Mahmood, Judy Savige

Summary: This study describes the ocular features in an individual with a homozygous LAMB2 pathogenic variant and compares the reported abnormalities in Pierson syndrome with those in Alport syndrome. The findings suggest that mutations in LAMB2 and COL4A5 have similar effects on basement membranes and the pathogenesis of ocular damage.

OPHTHALMIC GENETICS (2023)

Add to Collection
Review Pediatrics

Ocular manifestations of renal ciliopathies

Omar Salehi, Heather Mack, Deb Colville, Debbie Lewis, Judy Savige

Summary: This study reviewed the ocular associations of renal ciliopathies, a common cause of kidney failure in children and adults. Genes affected in renal ciliopathies were identified and their ocular expression and phenotype were examined. It was found that most pediatric-onset renal ciliopathies have ocular manifestations, but ocular abnormalities are uncommon in adult-onset cystic kidney diseases.

PEDIATRIC NEPHROLOGY (2023)

Add to Collection
Review Pediatrics

Ocular manifestations of the genetic causes of focal and segmental glomerulosclerosis

Victor Zhu, Tess Huang, David Wang, Deb Colville, Heather Mack, Judy Savige

Summary: This study examined FSGS-associated genes for ocular abnormalities and found that a significant proportion of these genes are associated with ocular features in human disease or in animal models. The presence of ocular manifestations suggests a genetic basis for FSGS and can help identify the affected gene. Ocular abnormalities require early evaluation and sometimes treatment to prevent visual loss, and the patient should also be examined for other syndromic features.

PEDIATRIC NEPHROLOGY (2023)

Add to Collection
Review Pediatrics

Ocular manifestations of congenital anomalies of the kidney and urinary tract (CAKUT)

James Virth, Heather G. Mack, Deb Colville, Emma Crockett, Judy Savige

Summary: Congenital anomalies of the kidney and urinary tract (CAKUT) are common birth defects worldwide, which can lead to kidney failure in children. This study investigated the ocular features associated with CAKUT-associated genes and found that a significant number of these genes also have ocular abnormalities. These findings suggest a genetic basis for both CAKUT and ocular anomalies in affected individuals.

PEDIATRIC NEPHROLOGY (2023)

Add to Collection
Review Immunology

Glomerulonephritis: immunopathogenesis and immunotherapy

Hans-Joachim Anders, A. Richard Kitching, Nelson Leung, Paola Romagnani

Summary: 'Glomerulonephritis' (GN) refers to a group of immune-mediated disorders characterized by inflammation of the kidney's filtration units. Current classification is based on histopathological lesion patterns, but these patterns do not align well with the diverse pathological mechanisms and do not guide optimal therapy. Instead, a proposed immunopathogenesis-based classification groups GN disorders into five categories, allowing for more targeted and effective treatments.

NATURE REVIEWS IMMUNOLOGY (2023)

Add to Collection
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.